1Tanaka M,Inase N,Miyake S,et al.Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma.Anticancer Res.2001,21(1A) :291-294.
2Curiel DT,Gerritsen WR,Krul MR,et al.Progress in cancer gene therapy.Cancer Gene Ther,2000,7(8):1197-1199.
3Sethi N,Palefsky J.Treatment of human papillomavirus(HPV)type 16-infected cells using herpes simplex virus type Ⅰ thymidine kinase-mediated gene therapy transcriptioually regulated by the HPV E2 protein.Hum Gene Ther,2003,14(1):45-57.
4Hayashi K,Hayashi T,Sun HD.et al.Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system.Hum Gene Ther,2002,13(3):415-423.
5Bilsland AE,Anderson CJ.Fletcher Monaghan AJ,et al.Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.Oncogene,2003,22(3):370-380.
6Yoshinouchi M,Hongo A,Takamoto N,et al.Alteration of the CDKN2/p16 gene is not required for HPV-positive uterine cervical cancer cell lines.Int J Oncol,2000,16(3) :537-541.
7Bruning A,Runnebaum IB.CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone,TNFalpha,and TGFbeta.Gene Ther,2003,10(3):198-205.
8Street D,Kaufmann AM,Vaughan A,et al.Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells.Gynecol Oncol,1997,65(2):265-272.
9Marthiner E,Divita G,Bernaud J,et al.Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter.Gene Ther,2000,7(14):1224-1233.
10Anuchapreeda S,Leechanachai P,Smith MM,et al.Modulation of P-glycoprotein expression and function by curcunin in multidrugresistant human KB cells.Biochem Pharmacol.2002,64(4):573-582.
